These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 1830582)
1. Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor. Granowitz EV; Clark BD; Mancilla J; Dinarello CA J Biol Chem; 1991 Aug; 266(22):14147-50. PubMed ID: 1830582 [TBL] [Abstract][Full Text] [Related]
2. Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: I. IL-1 receptor antagonist inhibits IL-1-induced cytokine synthesis and blocks the binding of IL-1 to its type II receptor on human monocytes. Granowitz EV; Clark BD; Vannier E; Callahan MV; Dinarello CA Blood; 1992 May; 79(9):2356-63. PubMed ID: 1533322 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody. McIntyre KW; Stepan GJ; Kolinsky KD; Benjamin WR; Plocinski JM; Kaffka KL; Campen CA; Chizzonite RA; Kilian PL J Exp Med; 1991 Apr; 173(4):931-9. PubMed ID: 1826128 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 receptor antagonist binds to the type II interleukin-1 receptor on B cells and neutrophils. Dripps DJ; Verderber E; Ng RK; Thompson RC; Eisenberg SP J Biol Chem; 1991 Oct; 266(30):20311-5. PubMed ID: 1834644 [TBL] [Abstract][Full Text] [Related]
5. Natural and recombinant interleukin 1 receptor antagonist does not inhibit human T-cell proliferation induced by mitogens, soluble antigens or allogeneic determinants. Nicod LP; el Habre F; Dayer JM Cytokine; 1992 Jan; 4(1):29-35. PubMed ID: 1535518 [TBL] [Abstract][Full Text] [Related]
6. Differential binding of IL-1 alpha and IL-1 beta to receptors on B and T cells. Scapigliati G; Ghiara P; Bartalini M; Tagliabue A; Boraschi D FEBS Lett; 1989 Jan; 243(2):394-8. PubMed ID: 2521831 [TBL] [Abstract][Full Text] [Related]
7. Characterization and identification of interleukin 1 receptors on bovine neutrophils. Lederer JA; Czuprynski CJ J Leukoc Biol; 1992 Jun; 51(6):586-90. PubMed ID: 1535356 [TBL] [Abstract][Full Text] [Related]
8. cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. Haskill S; Martin G; Van Le L; Morris J; Peace A; Bigler CF; Jaffe GJ; Hammerberg C; Sporn SA; Fong S Proc Natl Acad Sci U S A; 1991 May; 88(9):3681-5. PubMed ID: 1827201 [TBL] [Abstract][Full Text] [Related]
9. Interleukin 1 alpha and interleukin 1 beta bind to the same receptor on T cells. Kilian PL; Kaffka KL; Stern AS; Woehle D; Benjamin WR; Dechiara TM; Gubler U; Farrar JJ; Mizel SB; Lomedico PT J Immunol; 1986 Jun; 136(12):4509-14. PubMed ID: 2940296 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of interleukin-1 (alpha and beta), interleukin-2 secretion and surface expression of interleukin-2 receptor (IL-2R) by a novel cytokine interleukin-1 receptor antagonist (IL-1ra). Conti P; Panara MR; Porrini AM; Gambi D; Barbacane RC; Reale M; Bongrazio M; Dempsey RA Scand J Immunol; 1992 Jul; 36(1):27-33. PubMed ID: 1535451 [TBL] [Abstract][Full Text] [Related]
11. Heterogeneity in interleukin (IL)-1 receptors expressed on human B cell lines. Differences in the molecular properties of IL-1 alpha and IL-1 beta binding sites. Benjamin D; Wormsley S; Dower SK J Biol Chem; 1990 Jun; 265(17):9943-51. PubMed ID: 2141025 [TBL] [Abstract][Full Text] [Related]
13. Interaction of recombinant monocyte-derived interleukin 1 receptor antagonist with rheumatoid synovial cells. Arend WP; Coll BP Cytokine; 1991 Sep; 3(5):407-13. PubMed ID: 1836395 [TBL] [Abstract][Full Text] [Related]
14. The interleukin-1 receptor in Raji human B-lymphoma cells. Molecular characterization and evidence for receptor-mediated activation of gene expression. Horuk R; McCubrey JA Biochem J; 1989 Jun; 260(3):657-63. PubMed ID: 2527495 [TBL] [Abstract][Full Text] [Related]
15. Secretion of IL-1 beta, TNF-alpha, IL-8 and IL-1ra by human polymorphonuclear leukocytes in response to lipopolysaccharides from periodontopathic bacteria. Yoshimura A; Hara Y; Kaneko T; Kato I J Periodontal Res; 1997 Apr; 32(3):279-86. PubMed ID: 9138193 [TBL] [Abstract][Full Text] [Related]
16. Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist. Symons JA; Young PR; Duff GW Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1714-8. PubMed ID: 7878046 [TBL] [Abstract][Full Text] [Related]
17. Human interleukin-1 receptor antagonist. High yield expression in E. coli and examination of cysteine residues. Steinkasserer A; Solari R; Mott HR; Aplin RT; Robinson CC; Willis AC; Sim RB FEBS Lett; 1992 Sep; 310(1):63-5. PubMed ID: 1388125 [TBL] [Abstract][Full Text] [Related]
18. Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1 beta. Malyak M; Smith MF; Abel AA; Arend WP J Clin Immunol; 1994 Jan; 14(1):20-30. PubMed ID: 8132734 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction. Dripps DJ; Brandhuber BJ; Thompson RC; Eisenberg SP J Biol Chem; 1991 Jun; 266(16):10331-6. PubMed ID: 1828071 [TBL] [Abstract][Full Text] [Related]
20. Properties of a specific interleukin 1 (IL 1) receptor on human Epstein Barr virus-transformed B lymphocytes: identity of the receptor for IL 1-alpha and IL 1-beta. Matsushima K; Akahoshi T; Yamada M; Furutani Y; Oppenheim JJ J Immunol; 1986 Jun; 136(12):4496-502. PubMed ID: 3011895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]